Quintiles.com

  • Biosimilars

  • clinical-trials-header
  • Quintiles Clinical Trial

    The first biosimilar products to market will reap the greatest rewards. And gaining regulatory approval is just one of many hurdles to success. 

    Quintiles offers the full range of expertise – scientific, technical, regulatory, clinical, registration and commercialization – critical to developing biologics, bio-betters and biosimilars. Combine that with our dedicated biosimilar intelligence team, and we can help accelerate your product’s success. 

    The expertise to manage risk and optimize biosimilar development

    If you’re considering how to best approach the unique challenges of biosimilars, you’re not alone. Quintiles works with all types of customers engaged in the biologics and biosimilar markets. To increase your potential for success, it’s important to incorporate a biosimilar’s commercial requirements early in development with a partner who has the integrated expertise and flexible strategy to help you succeed.

    More on Biosimilars

  • New thinking on the biosimilar opportunity

  • Quintiles Clinical Trails

    As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome unique challenges.
    Read white paper

  • Quintiles Clinical Trails

    Dr. Amar Kureishi, Regional Chief Medical Officer, Asia-Pacific, Quintiles, discusses the main drivers behind the growth of biosimilars. Listen here